Page 2 - Davidk Shay News Today : Breaking News, Live Updates & Top Stories | Vimarsana

VAERS received and processed
††† 13,725 adverse event reports for Janssen COVID-19 vaccine recipients; median age was 42 years, and 66% were women (Table 1). Among these VAERS reports, 13,294 (97%) were classified as nonserious, and 343 (3%) were classified as serious, including three reports of non-CVST TTS (no deaths). Two of the TTS cases occurred among women aged 30–39 years and one in a woman aged 50–59 years. Each of these women had evidence of large-vessel thrombosis and thrombocytopenia (Table 2). As of April 25, 14 CVST cases had been confirmed (
8), for a total of 17 TTS cases.
CDC and FDA reviewed 88 reports of death after receipt of Janssen COVID-19 vaccine; death certificates were available for 12 (14%). Among the 88 reported decedents, 44 were female, 38 were male, and the sex of six was not reported (Table 1). The median decedent age was 69 years (range = 21–97 years); median interval from vaccination to death was 2 days (range = 0–23 d ....

United States , Ruiling Liu , Johnr Su , Tomt Shimabukuro , Thomasa Clark , Paige Marquez , Ritaf Helfand , Tanyar Myers , Charles Licata , Bicheng Zhang , Davidk Shay , Julianne Gee , Janssen Johnson , Janssen Biotech Inc , Response Team , International Committee Of Medical Journal Editors , Us Department Of Health , Human Services , Us Department , Drug Administration , Advisory Committee On Immunization Practices , Department Of Health , Emergency Use Authorization , Janssen Biotech , Janssen Pharmaceutical , Advisory Committee ,